Editorial: Heterogeneity of clinical phenotypes in type 1 diabetes and of beta cell deterioration in type 1 diabetes.
作者信息
Li Xia, Zhang Mei, Yan Jinhua, Liu Zhenqi
机构信息
National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
出版信息
Front Endocrinol (Lausanne). 2023 Jan 6;13:1120555. doi: 10.3389/fendo.2022.1120555. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Heterogeneity of clinical phenotypes in type 1 diabetes and of beta cell deterioration in type 1 diabetes.社论：1型糖尿病临床表型的异质性以及1型糖尿病中β细胞恶化的异质性
Front Endocrinol (Lausanne). 2023 Jan 6;13:1120555. doi: 10.3389/fendo.2022.1120555. eCollection 2022.
2
The clinical consequences of heterogeneity within and between different diabetes types.不同糖尿病类型内部和之间异质性的临床后果。
Diabetologia. 2020 Oct;63(10):2040-2048. doi: 10.1007/s00125-020-05211-7. Epub 2020 Sep 7.
3
The Continuing Evolution of Precision Health in Type 2 Diabetes: Achievements and Challenges.2 型糖尿病精准医学的持续演进：成就与挑战。
Curr Diab Rep. 2019 Feb 26;19(4):16. doi: 10.1007/s11892-019-1137-2.
4
The Need for Precision Medicine to be Applied to Diabetes.精准医学在糖尿病中的应用需求。
J Diabetes Sci Technol. 2020 Nov;14(6):1122-1128. doi: 10.1177/1932296819894295. Epub 2020 Jan 6.
5
Future Roadmaps for Precision Medicine Applied to Diabetes: Rising to the Challenge of Heterogeneity.精准医学应用于糖尿病的未来蓝图：应对异质性的挑战。
J Diabetes Res. 2018 Nov 27;2018:3061620. doi: 10.1155/2018/3061620. eCollection 2018.
6
Precision Medicine in Patients with Differential Diabetic Phenotypes: Novel Opportunities from Network Medicine.精准医学在具有不同糖尿病表型患者中的应用：网络医学带来的新机遇。
Curr Diabetes Rev. 2022;18(8):e221221199301. doi: 10.2174/1573399818666211222164400.
7
Phenotypic and genetic classification of diabetes.糖尿病的表型和基因型分类。
Diabetologia. 2022 Nov;65(11):1758-1769. doi: 10.1007/s00125-022-05769-4. Epub 2022 Aug 12.
8
Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children.儿童 2 型糖尿病的表型谱及病因。
Annu Rev Med. 2022 Jan 27;73:501-515. doi: 10.1146/annurev-med-042120-012033.
9
The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.触珠蛋白及其基因型在糖尿病血管并发症中的多效性作用。
Eur J Prev Cardiol. 2018 Sep;25(14):1502-1519. doi: 10.1177/2047487318776829. Epub 2018 May 25.
10
Visualizing heterogeneity in type 2 diabetes phenotype, outcome and drug response.可视化2型糖尿病表型、结局及药物反应中的异质性。
Nat Med. 2022 May;28(5):909-910. doi: 10.1038/s41591-022-01791-6.
本文引用的文献
1
Precision medicine in type 1 diabetes.1 型糖尿病的精准医学。
Diabetologia. 2022 Nov;65(11):1854-1866. doi: 10.1007/s00125-022-05778-3. Epub 2022 Aug 22.
2
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study.四组 2 型糖尿病导致新诊断个体的病因学和临床异质性：一项 IMI DIRECT 研究。
Cell Rep Med. 2022 Jan 4;3(1):100477. doi: 10.1016/j.xcrm.2021.100477. eCollection 2022 Jan 18.
3
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).《成人 1 型糖尿病管理：美国糖尿病协会 (ADA) 与欧洲糖尿病研究协会 (EASD) 的共识报告》
Diabetes Care. 2021 Nov;44(11):2589-2625. doi: 10.2337/dci21-0043. Epub 2021 Sep 30.
4
Three-phasic pattern of C-peptide decline in type 1 diabetes patients with partial remission.1型糖尿病部分缓解患者C肽下降的三相模式
Diabetes Metab Res Rev. 2021 Nov;37(8):e3461. doi: 10.1002/dmrr.3461. Epub 2021 May 7.
5
Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression.高危个体中的转录网络可识别 1 型糖尿病进展的特征。
Sci Transl Med. 2021 Mar 31;13(587). doi: 10.1126/scitranslmed.abd5666.
6
Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).精准医学与糖尿病：美国糖尿病协会（ADA）与欧洲糖尿病研究协会（EASD）的共识报告。
Diabetes Care. 2020 Jul;43(7):1617-1635. doi: 10.2337/dci20-0022.
7
Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years.多变量临床诊断模型的开发和验证，以识别 18-50 岁成年人中需要快速胰岛素治疗的 1 型糖尿病。
BMJ Open. 2019 Sep 26;9(9):e031586. doi: 10.1136/bmjopen-2019-031586.
8
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.近期诊断糖尿病患者亚组中糖尿病相关疾病的风险：一项为期 5 年的随访研究。
Lancet Diabetes Endocrinol. 2019 Sep;7(9):684-694. doi: 10.1016/S2213-8587(19)30187-1. Epub 2019 Jul 22.
9
Type 2 diabetes: a multifaceted disease.2 型糖尿病：一种多面性疾病。
Diabetologia. 2019 Jul;62(7):1107-1112. doi: 10.1007/s00125-019-4909-y. Epub 2019 Jun 3.
10
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data.基于临床试验数据的分析：与基于简单临床特征的模型相比，数据驱动的 2 型糖尿病亚组的疾病进展和治疗反应。
Lancet Diabetes Endocrinol. 2019 Jun;7(6):442-451. doi: 10.1016/S2213-8587(19)30087-7. Epub 2019 Apr 29.
Zotero 插件